Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Torsten P. M. Scheithauer, Elena Rampanelli, Max Nieuwdorp, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 457

Showing 26-50 of 457 citing articles:

Gut microbiota-gonadal axis: the impact of gut microbiota on reproductive functions
Victory Jesutoyosi Ashonibare, Bolaji A. Akorede, P. J. Ashonibare, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Exploring the Gut Microbiota: Key Insights into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes
Sabitha Sasidharan Pillai, Charles A. Gagnon, Christy Foster, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 11, pp. 2709-2719
Open Access | Times Cited: 17
Association between the dietary index for gut microbiota and diabetes: the mediating role of phenotypic age and body mass index
Yingxuan Huang, Xiaobo Liu, Chanchan Lin, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access | Times Cited: 4
Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications
Marta Potrykus, Sylwia Czaja-Stolc, Marta Stankiewicz, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 3839-3839
Open Access | Times Cited: 70
Recent advances in utilization of pectins in biomedical applications: a review focusing on molecular structure-directing health-promoting properties
Shikai Zhang, Geoffrey I. N. Waterhouse, Fangzhou Xu, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 19, pp. 3386-3419
Closed Access | Times Cited: 64
Diet, microbiota, and the mucus layer: The guardians of our health
Francesco Suriano, Elisabeth Nyström, Domenico Sergi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression
Charlotte M. Mosterd, Mehmet Kanbay, Bert‐Jan H. van den Born, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2021) Vol. 35, Iss. 3, pp. 101484-101484
Open Access | Times Cited: 62
From Gut Microbiota through Low-Grade Inflammation to Obesity: Key Players and Potential Targets
Claudia Vetrani, Andrea Di Nisio, Stavroula Α. Paschou, et al.
Nutrients (2022) Vol. 14, Iss. 10, pp. 2103-2103
Open Access | Times Cited: 54
The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus
Cristian-Ioan Crăciun, Maria Adriana Neag, Adrian Cătinean, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 308-308
Open Access | Times Cited: 52
Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus
Xin He, Jiping Sun, Chao Liu, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 755-765
Open Access | Times Cited: 52
Metabolic Syndrome and Overactive Bladder Syndrome May Share Common Pathophysiologies
Lin‐Nei Hsu, Ju‐Chuan Hu, Po-Yen Chen, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1957-1957
Open Access | Times Cited: 51
The gut peptide Reg3g links the small intestine microbiome to the regulation of energy balance, glucose levels, and gut function
Jae Hoon Shin, Nadejda Bozadjieva-Kramer, Yikai Shao, et al.
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1765-1778.e6
Open Access | Times Cited: 41
Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction
Małgorzata Józkowiak, Hanna Piotrowska‐Kempisty, Dominik Kobylarek, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 174-174
Open Access | Times Cited: 41
Relationship between Helicobacter pylori infection and gastrointestinal microecology
Wenting Xu, Liming Xu, Chengfu Xu
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 38
The Gut–Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases
Natalia Di Tommaso, Francesco Santopaolo, Antonio Gasbarrini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1470-1470
Open Access | Times Cited: 30
The gut microbiota‐astrocyte axis: Implications for type 2 diabetic cognitive dysfunction
Zi-han Li, Yayi Jiang, Caiyi Long, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. S1, pp. 59-73
Open Access | Times Cited: 28
The role of the oral microbiome in obesity and metabolic disease: potential systemic implications and effects on taste perception
Imke Schamarek, Lars Anders, Rima Chakaroun, et al.
Nutrition Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Microbiome Dysbiosis: A Pathological Mechanism at the Intersection of Obesity and Glaucoma
Salvatore Pezzino, Maria Sofia, Luigi Piero Greco, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1166-1166
Open Access | Times Cited: 25
Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety
Koen Wortelboer, Patrick A. de Jonge, Torsten P. M. Scheithauer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Distribution characteristics of oral microbiota and its relationship with intestinal microbiota in patients with type 2 diabetes mellitus
Xiaojing Guo, Shixuan Dai, Jin-di Lou, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 24
Understanding the Role of the Gut Microbiome in Diabetes and Therapeutics Targeting Leaky Gut: A Systematic Review
Aishwarya Sadagopan, Anas Mahmoud, Maha Begg, et al.
Cureus (2023)
Open Access | Times Cited: 24
Outer membrane vesicles derived from gut microbiota mediate tubulointerstitial inflammation: a potential new mechanism for diabetic kidney disease
Pei Pei Chen, Jia Xiu Zhang, Xue Qi Li, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 3988-4003
Open Access | Times Cited: 22
The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity
Julia Kopczyńska, Magdalena Kowalczyk
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Berberine prevents NAFLD and HCC by modulating metabolic disorders
Xinyue Lin, Jilei Zhang, Yajun Chu, et al.
Pharmacology & Therapeutics (2024) Vol. 254, pp. 108593-108593
Closed Access | Times Cited: 13
Health Benefits of Vegetarian Diets: An Insight into the Main Topics
Luciana Baroni, Gianluca Rizzo, A.V. Galchenko, et al.
Foods (2024) Vol. 13, Iss. 15, pp. 2398-2398
Open Access | Times Cited: 13

Scroll to top